Bristol Myers Squibb Reports Second Quarter Financial Results for 2024

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. CRWV
10. NOW

Go back to Bristol Myers Squibb Reports Second Quarter Financial Results for 2024

Bristol-Myers Squibb Co. (BMY) PT Raised to $57 at Goldman Sachs

July 29, 2024 7:18 AM EDT

Goldman Sachs analyst Chris Shibutani raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $57.00 (from $55.00) while maintaining a Buy rating.

The analyst comments "BMY's noteworthy outperformance on Friday July 26 (+~11% vs. flat XLV), while it occurred amidst favorable shifts in the broader market macro backdrop, was earned, in our... More

Bristol-Myers Squibb (BMY) stock gains after raising full-year guidance

July 26, 2024 7:51 AM EDT

Bristol-Myers Squibb (NYSE: BMY) shares rallied more than 5% premarket Friday as the company reported a robust second quarter, surpassing Wall Street's expectations for both earnings and revenue, and raised its full-year guidance.

The pharmaceutical giant posted adjusted earnings per share (EPS) of $2.07, significantly higher than the analyst estimate of $1.64. Revenue for the quarter was also strong at $12.2 billion, beating the consensus estimate of $11.52 billion and marking a 9% increase from the same quarter last year, or an 11% rise adjusting for foreign exchange.

The company's performance was propelled by its Growth Portfolio, which saw... More